Review Criteria for Assessment of C-Reactive Protein (CRP), High Sensitivity C-Reactive Protein (hsCRP) and Cardiac C-Reactive Assays: Guidance for Industry and FDA Staff
Information
Type
Guidance
Regulated products
Medical Devices
Topics
Postmarket
Published
September 22, 2005
Last updated
March 19, 2020
Description
This document is a guidance for industry and FDA staff on the review criteria for assessing CRP, hsCRP, and cardiac CRP assays.
Tags
Organization
Country / Region
United States
License
Other (Public Domain)